Instruction for use: Oftan Dipivefrin

Trade name of the drug – Strattera

Active substance: Dipivefrinum

ÀÒÕ Code S01EA02 Dipivefrin

Pharmacotherapeutic group:

Sympathomimetic drug

Ophthalmic agents

Nosological classification (ICD-10)

H40.0 Suspected glaucoma

H40.1 Primary open-angle glaucoma

H40.3 Glaucoma secondary posttraumatic

H40.4 Glaucoma secondary to inflammatory diseases of the eye

Composition1 ml of a clear, colorless solution containing 1 mg dipivefrin hydrochloride, plastic flakonah- 5 ml vial 1 in box.

Characteristic

The precursor of epinephrine, epinephrine formed by esterification with two molecules of pivalic acid.

Pharmachologic effect
antiglaucoma.

It stimulates beta-adrenergic receptors of the ciliary processes, affects the production of intraocular fluid (short and slightly increases, followed by a longer and greatly reduces), expands the pupil, has no significant effect on the eye accommodation.

Indications for Strattera
Elevated intraocular pressure, open angle glaucoma, glaucoma, cataract operated after some types of secondary glaucoma.

Contraindications for Strattera

Hypersensitivity, obstruction of the anterior chamber angle of the eye.

Pregnancy and breast-feeding

When pregnancy only on strict conditions; Breastfeeding - with caution (can be released with milk).

Side effects

Local: temporary irritation of the conjunctiva, pain and burning sensation in the eye, redness, allergic reactions (Blepharoconjunctivitis, hives and others.); long-term use - follicular conjunctivitis, conjunctival hyperemia resistant; in patients with aphakia - maculopathy, macular edema.

System: headache, rarely - tachycardia, arrythmia, increased blood pressure.

Strattera Dosage and Administration
1 drop into the affected eye two times a day.

Overdose

Symptoms: arrhythmia, extrasystole (disappear a few hours after cessation of use).

Treatment: symptomatic (e.g., propranolol).

Precautionary measures

Before the appointment should be made Gonioscopy, treatment should be under the control of intraocular pressure.

Patients with aphakia should be regularly examined for the development of macular edema.

Before burying contact lenses should be removed and re-set no earlier than 15 minutes after use of the drug (the possibility of precipitation they preservatives - benzalkonium chloride).

SPECIAL INSTRUCTIONS for Strattera

Safety and effectiveness in children have not been tested.

After opening the bottle dropper eye drops should be used within 1 month.

Storage conditions of Phenazepam
In a dry, dark place at a temperature of 2-15 ° C. Opening the bottle - at room temperature.

Keep out of the reach of children.
Shelf life of Strattera
2 years.
Do not use beyond the expiration date printed on the package.